What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Stroke
The scientist’s investigation covers issues in Stroke, Internal medicine, Anesthesia, Randomized controlled trial and Cardiology.
His research in Stroke intersects with topics in Aspirin and Surgery, Vascular disease.
His work in Internal medicine is not limited to one particular discipline; it also encompasses Physical therapy.
His Anesthesia study combines topics in areas such as Placebo, Intracerebral hemorrhage and Sumatriptan.
Hans-Christoph Diener works mostly in the field of Randomized controlled trial, limiting it down to topics relating to Clinical trial and, in certain cases, Multicenter trial.
His work carried out in the field of Cardiology brings together such families of science as Cryptogenic stroke and Subgroup analysis.
His most cited work include:
- Dabigatran versus warfarin in patients with atrial fibrillation (7970 citations)
- The International Classification of Headache Disorders, 3rd edition (beta version) (5079 citations)
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (3899 citations)
What are the main themes of his work throughout his whole career to date?
Hans-Christoph Diener mainly focuses on Internal medicine, Stroke, Migraine, Cardiology and Anesthesia.
Many of his research projects under Internal medicine are closely connected to In patient with In patient, tying the diverse disciplines of science together.
His research investigates the connection with Stroke and areas like Aspirin which intersect with concerns in Dipyridamole.
His study in Migraine is interdisciplinary in nature, drawing from both Physical therapy, Pediatrics and Sumatriptan.
Many of his studies on Cardiology involve topics that are commonly interrelated, such as Blood pressure.
His Anesthesia research includes elements of Tolerability, Adverse effect and Placebo.
He most often published in these fields:
- Internal medicine (33.30%)
- Stroke (27.34%)
- Migraine (21.28%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (33.30%)
- Stroke (27.34%)
- Atrial fibrillation (13.49%)
In recent papers he was focusing on the following fields of study:
Hans-Christoph Diener focuses on Internal medicine, Stroke, Atrial fibrillation, Cardiology and Migraine.
His work on Randomized controlled trial, Clinical trial and Confidence interval as part of general Internal medicine study is frequently linked to In patient, therefore connecting diverse disciplines of science.
As part of the same scientific family, Hans-Christoph Diener usually focuses on Stroke, concentrating on Dabigatran and intersecting with Thrombolysis.
The Stroke prevention research Hans-Christoph Diener does as part of his general Atrial fibrillation study is frequently linked to other disciplines of science, such as Left atrial appendage occlusion, therefore creating a link between diverse domains of science.
His work carried out in the field of Cardiology brings together such families of science as Patent foramen ovale and Ischemic stroke.
To a larger extent, Hans-Christoph Diener studies Anesthesia with the aim of understanding Migraine.
Between 2016 and 2021, his most popular works were:
- Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source (195 citations)
- The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2 (170 citations)
- Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial. (103 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Stroke
Hans-Christoph Diener spends much of his time researching Internal medicine, Stroke, Atrial fibrillation, Cardiology and Randomized controlled trial.
His study looks at the intersection of Internal medicine and topics like Placebo with Stroke recovery.
The concepts of his Stroke study are interwoven with issues in Surgery and Antithrombotic.
His Atrial fibrillation research is multidisciplinary, relying on both Prospective cohort study and Aspirin.
The Randomized controlled trial study combines topics in areas such as Odds ratio and Anesthesia.
The study incorporates disciplines such as Adverse effect and Ganglion in addition to Anesthesia.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
